Inventor · disambiguated record
Helle Naver
Also filed as: NAVER HELLE
4 granted patents·8 pending applications·30 citations·filing 2007–2015
72Inventor score
Top patents by PatentIndex Score
12 records- 0190US9481721B2Insulin formulationsNOVO NORDISK AS·Filed 2013·Granted Nov 1, 2016·13 cites·25 claims
- 0289US8324157B2Preparation comprising insulin, nicotinamide and an amino acidOLSEN HELLE BIRK·Filed 2011·Granted Dec 4, 2012·15 cites·43 claims
- 0374US8865647B2Pharmaceutical solution of non covalently bound albumin and acylated insulinNAVER HELLE·Filed 2010·Granted Oct 21, 2014·2 cites·11 claims
- 0459US2014206610A1Preparation Comprising Insulin, Nicotinamide and an Amino AcidNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 0559US2014329744A1Stable non-aqueous liquid pharmaceutical compositions comprising an insulinNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 0656US2013281364A1Preparation Comprising Insulin, Nicotinamide and an Amino AcidNOVO NORDISK AS·Filed 2012·Application pending·0 cites
- 0754US9896496B2Derivative of an insulin analogueNOVO NORDISK AS·Filed 2014·Granted Feb 20, 2018·0 cites·15 claims
- 0851US2009069216A1Single-Chain Insulin Analogues and Pharmaceutical Formulations ThereofNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 0949US2015182595A1Preparation Comprising Insulin, Nicotinamide and an Amino AcidNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1042US2011009314A1Single-Chain Insulin Analogues and Pharmaceutical Formulations ThereofNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 1139US2012196800A1Stable non-aqueous liquid pharmaceutical compositions comprising an insulinNAVER HELLE·Filed 2010·Application pending·0 cites
- 1239US2015111820A1Novel use of insulin derivativesNOVO NORDISK AS·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Helle Naver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →